Published in J Biol Chem on April 19, 2010
Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab (2014) 1.45
Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc Natl Acad Sci U S A (2011) 1.21
O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc Natl Acad Sci U S A (2012) 1.00
Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem (2012) 0.96
Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination. Mol Cell Proteomics (2013) 0.90
Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. J Mol Cell Biol (2015) 0.79
Removal of O-GlcNAcylation is important for pig preimplantation development. J Reprod Dev (2015) 0.78
Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin. PLoS One (2015) 0.75
Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines. Front Endocrinol (Lausanne) (2016) 0.75
The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol (2006) 10.76
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell (2003) 10.42
PEST sequences and regulation by proteolysis. Trends Biochem Sci (1996) 8.90
Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature (2007) 8.48
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (1989) 4.27
Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem (1997) 4.24
Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem (1991) 4.16
Skp2 regulates Myc protein stability and activity. Mol Cell (2003) 3.85
Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol (1987) 3.73
Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem (2004) 3.35
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J Biol Chem (1999) 3.13
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol (2006) 2.90
Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell (2002) 2.89
Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem (2005) 2.74
SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell (2007) 2.69
Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem (1997) 2.69
Dictyostelium myosin heavy chain phosphorylation sites regulate myosin filament assembly and localization in vivo. Cell (1993) 2.61
Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem (2003) 2.59
Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem (2001) 2.58
Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol (2004) 2.56
O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell (2003) 2.51
Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol (1997) 2.45
Proteolysis and the G1-S transition: the SCF connection. Curr Opin Genet Dev (1998) 2.35
Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry (2001) 2.24
Constitutive activation of Mek1 by mutation of serine phosphorylation sites. Proc Natl Acad Sci U S A (1994) 2.22
Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J (2001) 1.94
Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem (2002) 1.88
O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem (2006) 1.79
O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J Biol Chem (2004) 1.77
Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene (1996) 1.75
Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem (2004) 1.66
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A (2001) 1.60
Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes (2001) 1.53
SCF-mediated protein degradation and cell cycle control. Oncogene (2005) 1.48
The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem (2003) 1.42
Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry (2000) 1.35
O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol (2004) 1.33
Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J Biol Chem (2001) 1.33
The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys (2003) 1.33
Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci (2005) 1.32
O-GlcNAc and the control of gene expression. Biochim Biophys Acta (1999) 1.27
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. Biochim Biophys Acta (2003) 1.24
Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol (2003) 1.21
Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes (2002) 1.17
Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J (2008) 1.16
Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease. Biochim Biophys Acta (2009) 1.14
Structure of O-linked GlcNAc transferase: mediator of glycan-dependent signaling. Biochem Biophys Res Commun (2000) 1.13
Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol Biol Cell (2009) 1.07
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim Biophys Acta (1999) 1.06
Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. J Neurochem (1997) 0.99
70-kDa-heat shock protein presents an adjustable lectinic activity towards O-linked N-acetylglucosamine. Biochem Biophys Res Commun (2004) 0.99
Lactoferrin and transferrin: functional variations on a common structural framework. Biochem Cell Biol (2002) 0.98
Nucleoplasmic and cytoplasmic glycoproteins. Ciba Found Symp (1989) 0.95
O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon? Biochimie (2008) 0.93
Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway. J Cell Biochem (2007) 0.93
Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer (2005) 0.93
Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci U S A (1997) 0.92
The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated. Eur J Biochem (2004) 0.92
26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem Biophys Res Commun (2003) 0.90
Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells. J Cell Biochem (2005) 0.89
Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals (2004) 0.86
Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression. FEBS J (2007) 0.86
A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2alpha. Biochemistry (2003) 0.84
Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice. Cancer Lett (2003) 0.81
Expression of delta-lactoferrin induces cell cycle arrest. Biometals (2004) 0.81
An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem Biophys Res Commun (2003) 0.81
Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie (2008) 0.80
Characteristics of okadaic acid--induced cytotoxic effects in CHO K1 cells. Environ Toxicol (2003) 0.76
Lactoferrin structure and functions. Adv Exp Med Biol (2008) 1.22
Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals (2004) 0.95
Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer (2005) 0.93
Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression. FEBS J (2007) 0.86
Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem Cell Biol (2012) 0.82
Expression of delta-lactoferrin induces cell cycle arrest. Biometals (2004) 0.81
Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors. Glycobiology (2007) 0.80
Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie (2008) 0.80
Detection and identification of O-GlcNAcylated proteins by proteomic approaches. Proteomics (2015) 0.80
Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons. BMC Neurosci (2014) 0.79
Delta-lactoferrin induces cell death via the mitochondrial death signaling pathway by upregulating bax expression. Biometals (2014) 0.77
Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR. Biometals (2010) 0.77
Advances in lactoferrin research. Biochimie (2008) 0.76
Construction of a multi-functional helper-dependent adenovirus based system for cancer gene therapy. Asian Pac J Cancer Prev (2009) 0.75